APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals for Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2026-2032

27 December 2025203 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals for Diagnosis Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals for Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals for Diagnosis Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals for Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiopharmaceuticals for Diagnosis is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Radiopharmaceuticals for Diagnosis, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiopharmaceuticals for Diagnosis, also provides the sales of main regions and countries. Of the upcoming market potential for Radiopharmaceuticals for Diagnosis, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiopharmaceuticals for Diagnosis sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiopharmaceuticals for Diagnosis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Radiopharmaceuticals for Diagnosis sales, projected growth trends, production technology, application and end-user industry.

Radiopharmaceuticals for Diagnosis Segment by Company

Atom High-tech Co., Ltd.

Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory

Tianjin Said Biopharmaceutical Co., Ltd.

Shenzhen Larven Bioengineering Technology Co., Ltd.

Shanghai Atom Kexing Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd.

Ningbo Jun'an Pharmaceutical Technology Co., Ltd.

Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.

Guangdong Xi'ai Pharmaceutical Co., Ltd.

Chengdu Zhonghe Gaotong Isotope Co., Ltd.

Chengdu Yunke Pharmaceutical Co., Ltd.

Chengdu Xinke Pharmaceutical Co., Ltd.

Beijing Zhibo High-tech Biotechnology Co., Ltd.

RadioMedix, Inc.

PDRadiopharma Inc.

Lantheus

Jubilant Radiopharma

GE Healthcare Ltd

DOE IP

Radiopharmaceuticals for Diagnosis Segment by Type

Strontium [89Sr] Chloride

Sodium Iodide [131I]

Iodine [125I] Sealed Seed Source

Technetium [99mTc] Pentetate

Technetium [99mTc] Polymerized Albumin

Technetium [99mTc] Dithiodithiocarbamate

Other

Radiopharmaceuticals for Diagnosis Segment by Application

Hospital

Clinic

Other

Radiopharmaceuticals for Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Radiopharmaceuticals for Diagnosis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceuticals for Diagnosis sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Strontium [89Sr] Chloride Major Manufacturers Table 3. Sodium Iodide [131I] Major Manufacturers Table 4. Iodine [125I] Sealed Seed Source Major Manufacturers Table 5. Technetium [99mTc] Pentetate Major Manufacturers Table 6. Technetium [99mTc] Polymerized Albumin Major Manufacturers Table 7. Technetium [99mTc] Dithiodithiocarbamate Major Manufacturers Table 8. Other Major Manufacturers Table 9. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Hospital Major Manufacturers Table 11. Clinic Major Manufacturers Table 12. Other Major Manufacturers Table 13. Radiopharmaceuticals for Diagnosis Industry Trends Table 14. Radiopharmaceuticals for Diagnosis Industry Drivers Table 15. Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges Table 16. Radiopharmaceuticals for Diagnosis Industry Restraints Table 17. Global Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2026) Table 21. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2027-2032) Table 22. Global Radiopharmaceuticals for Diagnosis Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units) Table 24. Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032) & (K Units) Table 25. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2026) Table 26. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2027-2032) Table 27. Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2021-2026) Table 31. Global Radiopharmaceuticals for Diagnosis Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Radiopharmaceuticals for Diagnosis Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Radiopharmaceuticals for Diagnosis Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Radiopharmaceuticals for Diagnosis Manufacturers, Product Type & Application Table 35. Global Radiopharmaceuticals for Diagnosis Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Radiopharmaceuticals for Diagnosis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Radiopharmaceuticals for Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026) Table 42. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2027-2032) Table 43. Global Radiopharmaceuticals for Diagnosis Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 45. Global Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 46. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026) Table 47. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2027-2032) Table 48. Global Radiopharmaceuticals for Diagnosis Price by Type (2021-2026) & (US$/Unit) Table 49. Global Radiopharmaceuticals for Diagnosis Price by Type (2027-2032) & (US$/Unit) Table 50. Global Radiopharmaceuticals for Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2026) Table 54. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2027-2032) Table 55. Global Radiopharmaceuticals for Diagnosis Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 57. Global Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 58. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026) Table 59. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2027-2032) Table 60. Global Radiopharmaceuticals for Diagnosis Price by Application (2021-2026) & (US$/Unit) Table 61. Global Radiopharmaceuticals for Diagnosis Price by Application (2027-2032) & (US$/Unit) Table 62. Atom High-tech Co., Ltd. Company Information Table 63. Atom High-tech Co., Ltd. Business Overview Table 64. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 66. Atom High-tech Co., Ltd. Recent Development Table 67. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information Table 68. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview Table 69. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio Table 71. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Development Table 72. Tianjin Said Biopharmaceutical Co., Ltd. Company Information Table 73. Tianjin Said Biopharmaceutical Co., Ltd. Business Overview Table 74. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 76. Tianjin Said Biopharmaceutical Co., Ltd. Recent Development Table 77. Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information Table 78. Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview Table 79. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 81. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Development Table 82. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information Table 83. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview Table 84. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 86. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Development Table 87. Shanghai Xinke Pharmaceutical Co., Ltd. Company Information Table 88. Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview Table 89. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 91. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Development Table 92. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information Table 93. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview Table 94. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 96. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Development Table 97. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information Table 98. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview Table 99. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 101. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Development Table 102. Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information Table 103. Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview Table 104. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 106. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Development Table 107. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information Table 108. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview Table 109. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 111. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Development Table 112. Chengdu Yunke Pharmaceutical Co., Ltd. Company Information Table 113. Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview Table 114. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 116. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Development Table 117. Chengdu Xinke Pharmaceutical Co., Ltd. Company Information Table 118. Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview Table 119. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 121. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Development Table 122. Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information Table 123. Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview Table 124. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 126. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Development Table 127. RadioMedix, Inc. Company Information Table 128. RadioMedix, Inc. Business Overview Table 129. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 131. RadioMedix, Inc. Recent Development Table 132. PDRadiopharma Inc. Company Information Table 133. PDRadiopharma Inc. Business Overview Table 134. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 136. PDRadiopharma Inc. Recent Development Table 137. Lantheus Company Information Table 138. Lantheus Business Overview Table 139. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio Table 141. Lantheus Recent Development Table 142. Jubilant Radiopharma Company Information Table 143. Jubilant Radiopharma Business Overview Table 144. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio Table 146. Jubilant Radiopharma Recent Development Table 147. GE Healthcare Ltd Company Information Table 148. GE Healthcare Ltd Business Overview Table 149. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio Table 151. GE Healthcare Ltd Recent Development Table 152. DOE IP Company Information Table 153. DOE IP Business Overview Table 154. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio Table 156. DOE IP Recent Development Table 157. North America Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 158. North America Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 159. North America Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 160. North America Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 161. North America Radiopharmaceuticals for Diagnosis Sales Price by Type (2021-2026) & (US$/Unit) Table 162. North America Radiopharmaceuticals for Diagnosis Sales Price by Type (2027-2032) & (US$/Unit) Table 163. North America Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 164. North America Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 165. North America Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 166. North America Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 167. North America Radiopharmaceuticals for Diagnosis Sales Price by Application (2021-2026) & (US$/Unit) Table 168. North America Radiopharmaceuticals for Diagnosis Sales Price by Application (2027-2032) & (US$/Unit) Table 169. North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. North America Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 174. North America Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 175. North America Radiopharmaceuticals for Diagnosis Sales Price by Country (2021-2026) & (US$/Unit) Table 176. North America Radiopharmaceuticals for Diagnosis Sales Price by Country (2027-2032) & (US$/Unit) Table 177. United States Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 178. Canada Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 179. Mexico Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 180. Europe Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 181. Europe Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 182. Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 183. Europe Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 184. Europe Radiopharmaceuticals for Diagnosis Sales Price by Type (2021-2026) & (US$/Unit) Table 185. Europe Radiopharmaceuticals for Diagnosis Sales Price by Type (2027-2032) & (US$/Unit) Table 186. Europe Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 187. Europe Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 188. Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 189. Europe Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 190. Europe Radiopharmaceuticals for Diagnosis Sales Price by Application (2021-2026) & (US$/Unit) Table 191. Europe Radiopharmaceuticals for Diagnosis Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 197. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 198. Europe Radiopharmaceuticals for Diagnosis Sales Price by Country (2021-2026) & (US$/Unit) Table 199. Europe Radiopharmaceuticals for Diagnosis Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Germany Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 201. France Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 202. U.K. Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 203. Italy Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 204. Russia Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 205. Spain Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 206. Netherlands Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 207. Switzerland Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 208. Sweden Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 209. Poland Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 210. China Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 211. China Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 212. China Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 213. China Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 214. China Radiopharmaceuticals for Diagnosis Sales Price by Type (2021-2026) & (US$/Unit) Table 215. China Radiopharmaceuticals for Diagnosis Sales Price by Type (2027-2032) & (US$/Unit) Table 216. China Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 217. China Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 218. China Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 219. China Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 220. China Radiopharmaceuticals for Diagnosis Sales Price by Application (2021-2026) & (US$/Unit) Table 221. China Radiopharmaceuticals for Diagnosis Sales Price by Application (2027-2032) & (US$/Unit) Table 222. Asia Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 223. Asia Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 224. Asia Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 225. Asia Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 226. Asia Radiopharmaceuticals for Diagnosis Sales Price by Type (2021-2026) & (US$/Unit) Table 227. Asia Radiopharmaceuticals for Diagnosis Sales Price by Type (2027-2032) & (US$/Unit) Table 228. Asia Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 229. Asia Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 230. Asia Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 231. Asia Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 232. Asia Radiopharmaceuticals for Diagnosis Sales Price by Application (2021-2026) & (US$/Unit) Table 233. Asia Radiopharmaceuticals for Diagnosis Sales Price by Application (2027-2032) & (US$/Unit) Table 234. Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. Asia Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 238. Asia Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 239. Asia Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 240. Asia Radiopharmaceuticals for Diagnosis Sales Price by Country (2021-2026) & (US$/Unit) Table 241. Asia Radiopharmaceuticals for Diagnosis Sales Price by Country (2027-2032) & (US$/Unit) Table 242. Japan Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 243. South Korea Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 244. India Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 245. Australia Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 246. Taiwan Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 247. Southeast Asia Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 248. SAMEA Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (US$ Million) Table 249. SAMEA Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (US$ Million) Table 250. SAMEA Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 251. SAMEA Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 252. SAMEA Radiopharmaceuticals for Diagnosis Sales Price by Type (2021-2026) & (US$/Unit) Table 253. SAMEA Radiopharmaceuticals for Diagnosis Sales Price by Type (2027-2032) & (US$/Unit) Table 254. SAMEA Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (US$ Million) Table 255. SAMEA Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (US$ Million) Table 256. SAMEA Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 257. SAMEA Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 258. SAMEA Radiopharmaceuticals for Diagnosis Sales Price by Application (2021-2026) & (US$/Unit) Table 259. SAMEA Radiopharmaceuticals for Diagnosis Sales Price by Application (2027-2032) & (US$/Unit) Table 260. SAMEA Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 261. SAMEA Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 262. SAMEA Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 263. SAMEA Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 264. SAMEA Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 265. SAMEA Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 266. SAMEA Radiopharmaceuticals for Diagnosis Sales Price by Country (2021-2026) & (US$/Unit) Table 267. SAMEA Radiopharmaceuticals for Diagnosis Sales Price by Country (2027-2032) & (US$/Unit) Table 268. Brazil Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 269. Argentina Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 270. Chile Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 271. Colombia Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 272. Peru Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 273. Saudi Arabia Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 274. Israel Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 275. UAE Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 276. Turkey Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 277. Iran Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 278. Egypt Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Table 279. Key Raw Materials Table 280. Raw Materials Key Suppliers Table 281. Radiopharmaceuticals for Diagnosis Distributors List Table 282. Radiopharmaceuticals for Diagnosis Customers List Table 283. Research Programs/Design for This Report Table 284. Authors List of This Report Table 285. Secondary Sources Table 286. Primary Sources List of Figures Figure 1. Radiopharmaceuticals for Diagnosis Image Figure 2. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals for Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 4. Strontium [89Sr] Chloride Image Figure 5. Sodium Iodide [131I] Image Figure 6. Iodine [125I] Sealed Seed Source Image Figure 7. Technetium [99mTc] Pentetate Image Figure 8. Technetium [99mTc] Polymerized Albumin Image Figure 9. Technetium [99mTc] Dithiodithiocarbamate Image Figure 10. Other Image Figure 11. Global Radiopharmaceuticals for Diagnosis Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Radiopharmaceuticals for Diagnosis Market Size Share 2021 VS 2025 VS 2032 Figure 13. Hospital Image Figure 14. Clinic Image Figure 15. Other Image Figure 16. Global Radiopharmaceuticals for Diagnosis Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Figure 18. Global Radiopharmaceuticals for Diagnosis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2032) Figure 21. Global Radiopharmaceuticals for Diagnosis Sales (2021-2032) & (K Units) Figure 22. Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Radiopharmaceuticals for Diagnosis Sales YoY (2021-2032) & (K Units) Figure 25. Europe Radiopharmaceuticals for Diagnosis Sales YoY (2021-2032) & (K Units) Figure 26. China Radiopharmaceuticals for Diagnosis Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Radiopharmaceuticals for Diagnosis Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales YoY (2021-2032) & (K Units) Figure 29. Global Radiopharmaceuticals for Diagnosis Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Radiopharmaceuticals for Diagnosis Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2032) Figure 35. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2032) Figure 38. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2032) Figure 41. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2032) Figure 44. North America Radiopharmaceuticals for Diagnosis Revenue Share by Type (2021-2032) Figure 45. North America Radiopharmaceuticals for Diagnosis Sales Share by Type (2021-2032) Figure 46. North America Radiopharmaceuticals for Diagnosis Revenue Share by Application (2021-2032) Figure 47. North America Radiopharmaceuticals for Diagnosis Sales Share by Application (2021-2032) Figure 48. North America Radiopharmaceuticals for Diagnosis Revenue Share by Country (2021-2032) Figure 49. North America Radiopharmaceuticals for Diagnosis Sales Share by Country (2021-2032) Figure 50. Europe Radiopharmaceuticals for Diagnosis Revenue Sh

Scope & coverage.

Types
  • Strontium [89Sr] Chloride
  • Sodium Iodide [131I]
  • Iodine [125I] Sealed Seed Source
  • Technetium [99mTc] Pentetate
  • Technetium [99mTc] Polymerized Albumin
  • Technetium [99mTc] Dithiodithiocarbamate
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Atom High-tech Co., Ltd.
  • Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  • Tianjin Said Biopharmaceutical Co., Ltd.
  • Shenzhen Larven Bioengineering Technology Co., Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  • Shanghai Xinke Pharmaceutical Co., Ltd.
  • Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  • Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  • Guangdong Xi'ai Pharmaceutical Co., Ltd.
  • Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  • Chengdu Yunke Pharmaceutical Co., Ltd.
  • Chengdu Xinke Pharmaceutical Co., Ltd.
  • Beijing Zhibo High-tech Biotechnology Co., Ltd.
  • RadioMedix, Inc.
  • PDRadiopharma Inc.
  • Lantheus
  • Jubilant Radiopharma
  • GE Healthcare Ltd
  • DOE IP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Radiopharmaceuticals for Diagnosis Market by Type
  3. 1.2.1 Global Radiopharmaceuticals for Diagnosis Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Strontium [89Sr] Chloride
  5. 1.2.3 Sodium Iodide [131I]
  6. 1.2.4 Iodine [125I] Sealed Seed Source
  7. 1.2.5 Technetium [99mTc] Pentetate
  8. 1.2.6 Technetium [99mTc] Polymerized Albumin
  9. 1.2.7 Technetium [99mTc] Dithiodithiocarbamate
  10. 1.2.8 Other
  11. 1.3 Radiopharmaceuticals for Diagnosis Market by Application
  12. 1.3.1 Global Radiopharmaceuticals for Diagnosis Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Hospital
  14. 1.3.3 Clinic
  15. 1.3.4 Other
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Radiopharmaceuticals for Diagnosis Market Dynamics
  1. 2.1 Radiopharmaceuticals for Diagnosis Industry Trends
  2. 2.2 Radiopharmaceuticals for Diagnosis Industry Drivers
  3. 2.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals for Diagnosis Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Radiopharmaceuticals for Diagnosis Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region
  3. 3.2.1 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026)
  5. 3.2.3 Global Radiopharmaceuticals for Diagnosis Revenue by Region (2027-2032)
  6. 3.2.4 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Radiopharmaceuticals for Diagnosis Sales by Region
  9. 3.4.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026)
  11. 3.4.3 Global Radiopharmaceuticals for Diagnosis Sales by Region (2027-2032)
  12. 3.4.4 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers
  2. 4.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Radiopharmaceuticals for Diagnosis Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers
  6. 4.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Radiopharmaceuticals for Diagnosis Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Radiopharmaceuticals for Diagnosis Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Radiopharmaceuticals for Diagnosis Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Radiopharmaceuticals for Diagnosis Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Radiopharmaceuticals for Diagnosis Manufacturers, Product Type & Application
  13. 4.7 Global Radiopharmaceuticals for Diagnosis Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Radiopharmaceuticals for Diagnosis Market CR5 and HHI
  16. 4.8.2 2025 Radiopharmaceuticals for Diagnosis Tier 1, Tier 2, and Tier 3
5 Radiopharmaceuticals for Diagnosis Market by Type
  1. 5.1 Global Radiopharmaceuticals for Diagnosis Revenue by Type
  2. 5.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Radiopharmaceuticals for Diagnosis Sales by Type
  6. 5.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2032)
  9. 5.3 Global Radiopharmaceuticals for Diagnosis Price by Type
6 Radiopharmaceuticals for Diagnosis Market by Application
  1. 6.1 Global Radiopharmaceuticals for Diagnosis Revenue by Application
  2. 6.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Radiopharmaceuticals for Diagnosis Sales by Application
  6. 6.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2032)
  9. 6.3 Global Radiopharmaceuticals for Diagnosis Price by Application
7 Company Profiles
  1. 7.1 Atom High-tech Co., Ltd.
  2. 7.1.1 Atom High-tech Co., Ltd. Company Information
  3. 7.1.2 Atom High-tech Co., Ltd. Business Overview
  4. 7.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  6. 7.1.5 Atom High-tech Co., Ltd. Recent Developments
  7. 7.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  8. 7.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
  9. 7.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
  10. 7.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
  12. 7.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
  13. 7.3 Tianjin Said Biopharmaceutical Co., Ltd.
  14. 7.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  18. 7.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
  20. 7.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
  21. 7.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
  22. 7.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  24. 7.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
  25. 7.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  26. 7.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  30. 7.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 Shanghai Xinke Pharmaceutical Co., Ltd.
  32. 7.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  36. 7.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  38. 7.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
  39. 7.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
  40. 7.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  42. 7.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
  43. 7.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  44. 7.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
  45. 7.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
  46. 7.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  48. 7.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
  49. 7.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
  50. 7.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
  51. 7.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
  52. 7.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  54. 7.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
  55. 7.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  56. 7.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
  57. 7.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
  58. 7.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  60. 7.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
  61. 7.11 Chengdu Yunke Pharmaceutical Co., Ltd.
  62. 7.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
  63. 7.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
  64. 7.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  66. 7.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
  67. 7.12 Chengdu Xinke Pharmaceutical Co., Ltd.
  68. 7.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
  69. 7.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
  70. 7.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  72. 7.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
  73. 7.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
  74. 7.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
  75. 7.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
  76. 7.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  78. 7.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
  79. 7.14 RadioMedix, Inc.
  80. 7.14.1 RadioMedix, Inc. Company Information
  81. 7.14.2 RadioMedix, Inc. Business Overview
  82. 7.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  84. 7.14.5 RadioMedix, Inc. Recent Developments
  85. 7.15 PDRadiopharma Inc.
  86. 7.15.1 PDRadiopharma Inc. Company Information
  87. 7.15.2 PDRadiopharma Inc. Business Overview
  88. 7.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  90. 7.15.5 PDRadiopharma Inc. Recent Developments
  91. 7.16 Lantheus
  92. 7.16.1 Lantheus Company Information
  93. 7.16.2 Lantheus Business Overview
  94. 7.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
  96. 7.16.5 Lantheus Recent Developments
  97. 7.17 Jubilant Radiopharma
  98. 7.17.1 Jubilant Radiopharma Company Information
  99. 7.17.2 Jubilant Radiopharma Business Overview
  100. 7.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
  102. 7.17.5 Jubilant Radiopharma Recent Developments
  103. 7.18 GE Healthcare Ltd
  104. 7.18.1 GE Healthcare Ltd Company Information
  105. 7.18.2 GE Healthcare Ltd Business Overview
  106. 7.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
  108. 7.18.5 GE Healthcare Ltd Recent Developments
  109. 7.19 DOE IP
  110. 7.19.1 DOE IP Company Information
  111. 7.19.2 DOE IP Business Overview
  112. 7.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
  114. 7.19.5 DOE IP Recent Developments
8 North America
  1. 8.1 North America Radiopharmaceuticals for Diagnosis Market Size by Type
  2. 8.1.1 North America Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  3. 8.1.2 North America Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  4. 8.1.3 North America Radiopharmaceuticals for Diagnosis Price by Type (2021-2032)
  5. 8.2 North America Radiopharmaceuticals for Diagnosis Market Size by Application
  6. 8.2.1 North America Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  7. 8.2.2 North America Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  8. 8.2.3 North America Radiopharmaceuticals for Diagnosis Price by Application (2021-2032)
  9. 8.3 North America Radiopharmaceuticals for Diagnosis Market Size by Country
  10. 8.3.1 North America Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Radiopharmaceuticals for Diagnosis Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Radiopharmaceuticals for Diagnosis Market Size by Type
  2. 9.1.1 Europe Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  3. 9.1.2 Europe Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  4. 9.1.3 Europe Radiopharmaceuticals for Diagnosis Price by Type (2021-2032)
  5. 9.2 Europe Radiopharmaceuticals for Diagnosis Market Size by Application
  6. 9.2.1 Europe Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  7. 9.2.2 Europe Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  8. 9.2.3 Europe Radiopharmaceuticals for Diagnosis Price by Application (2021-2032)
  9. 9.3 Europe Radiopharmaceuticals for Diagnosis Market Size by Country
  10. 9.3.1 Europe Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Radiopharmaceuticals for Diagnosis Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Radiopharmaceuticals for Diagnosis Market Size by Type
  2. 10.1.1 China Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  3. 10.1.2 China Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  4. 10.1.3 China Radiopharmaceuticals for Diagnosis Price by Type (2021-2032)
  5. 10.2 China Radiopharmaceuticals for Diagnosis Market Size by Application
  6. 10.2.1 China Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  7. 10.2.2 China Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  8. 10.2.3 China Radiopharmaceuticals for Diagnosis Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Radiopharmaceuticals for Diagnosis Market Size by Type
  2. 11.1.1 Asia Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  3. 11.1.2 Asia Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  4. 11.1.3 Asia Radiopharmaceuticals for Diagnosis Price by Type (2021-2032)
  5. 11.2 Asia Radiopharmaceuticals for Diagnosis Market Size by Application
  6. 11.2.1 Asia Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  7. 11.2.2 Asia Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  8. 11.2.3 Asia Radiopharmaceuticals for Diagnosis Price by Application (2021-2032)
  9. 11.3 Asia Radiopharmaceuticals for Diagnosis Market Size by Country
  10. 11.3.1 Asia Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Radiopharmaceuticals for Diagnosis Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Radiopharmaceuticals for Diagnosis Market Size by Type
  2. 12.1.1 SAMEA Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Radiopharmaceuticals for Diagnosis Price by Type (2021-2032)
  5. 12.2 SAMEA Radiopharmaceuticals for Diagnosis Market Size by Application
  6. 12.2.1 SAMEA Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Radiopharmaceuticals for Diagnosis Price by Application (2021-2032)
  9. 12.3 SAMEA Radiopharmaceuticals for Diagnosis Market Size by Country
  10. 12.3.1 SAMEA Radiopharmaceuticals for Diagnosis Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Radiopharmaceuticals for Diagnosis Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Radiopharmaceuticals for Diagnosis Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
  2. 13.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Radiopharmaceuticals for Diagnosis Production Mode & Process
  6. 13.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Radiopharmaceuticals for Diagnosis Distributors
  9. 13.2.3 Radiopharmaceuticals for Diagnosis Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst